Advertisement Sidebar
Recent Posts
- Encorafenib + cetuximab (EC) BREAKWATER Study Reveals Breakthrough in Treating BRAF V600E-Mutant Metastatic Colorectal Cancer
- ctDNA & Trastuzumab Deruxtecan a New Frontier in Oesophagogastric Adenocarcinoma the DECIPHER Trial
- Everolimus Plus Lanreotide Shows Significant Benefits in New Standard in GEP-NET Treatment
- BRCA Carriers Slicing Breast Cancer Odds: Does Surgery Lead to Longevity Leaps?
- Palbociclib (IBRANCE) Revs Up Metastatic Breast Cancer in PATINA Results
Oncology Conference Videos
Oncology News
At ASH 2023, there is a discussion with Dr. Davide Matino, Assistant Professor of Medicine at…
In the groundbreaking study conducted by Bruce Feinberg,DO, Chief Medical Officer at Cardinal Health, the…
Allen Wilbanks finds himself at SABCS 2023, where he engages in a discussion with Dr.…
Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…
By: Hope Rugo, MD Date: 12/9/2023 At the SABCS 2023 conference, medical oncologist Hope Rugo…
In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…
Evandro Bezerra, MD, hematologist and assistant professor at The Ohio State University Wexner Medical Center,…
In a discussion on cancer science, Wassim Mchayleh, MD, explores the role of Minimal Residual…
By. Kellogg Parsons, MD Date: 12/07/2023 Kellogg Parsons, MD, a medical doctor and Vice President of…
By: Julie Lang, MD Date. 12/07/2023Julie Lang, MD, a medical professional known for expertise in…
Introduction to Myelofibrosis and JAK Inhibitors Myelofibrosis, a complex myeloproliferative neoplasm, presents a unique set…